WEEK 32 – N°7 of “MyList” with * * * stocks: Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

* * * stock
Average yearly return: +47%

Insulet posted revenues of $226.30 million for the quarter ended June 2020. This compares to year-ago revenues of $177.14 million. 

Strong buy
Strong sell
Only a feeling

If you found this site useful and want to help keep it alive, 

Buy Me A Coffee
We Love Coffee

 to cover the costs and keep the site free of advertisements! Thank you for your support!

Over BillBull

Investment strategist. Never ask me why: 'T.A.' only

Geef een antwoord

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

Deze website gebruikt Akismet om spam te verminderen. Bekijk hoe je reactie-gegevens worden verwerkt.